Selective inactivation of NADPH oxidase 2 causes regression of vascularization and the size and stability of atherosclerotic plaquesIván Quesada, Célio José de Castro, Eugenia Cifuentes-Pagano et al.|Atherosclerosis|2015Cited by 55
Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular DiseaseCarmen Ivorra, Vicente Andrés, H. Samyn et al.|Current Pharmaceutical Biotechnology|2003Cited by 10